A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-64264681 in Healthy Male and Female Participants
Clinical trial NCT03607513 · COMPLETED
Trial details
- NCT number
- NCT03607513
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-31
- Primary completion
- 2019-08-09
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.